Cannabis Testing Market — Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016–2024

Cannabis Testing Market Overview:

Cannabis is a flowering plant predominantly found is Africa, Asia, and the Americas. Cannabis is non-conventionally used as a hemp fiber, hemp oils, used for medicinal resolutions, and as a frivolous drug. Industrial hemp crops are produced from the cannabis plants, which produce a plenty of fiber. To gratify the UN Narcotics Convention, some of the cannabis strains are raised to produce nominal levels of tetrahydrocannabinol, the main psychoactive component. There are large number of plants, which are selectively raised to produce trahydrocannabinol, which is found by curing the flowers. Some of the other compounds, which include hashish and hash oil, are mined from the cannabis plant. These compounds are also used in testing procedure and thus, this would boost the cannabis testing market.

Fill the form for an exclusive sample of this report @ https://www.coherentmarketinsights.com/insight/request-sample/170

Despite regulatory challenges, the future of cannabis testing market is promising

In August 2016, the Drug Enforcement Agency (DEA) left its decision of classifying cannabis as a Schedule 1, deeming it to be a dangerous narcotic. This decision, however, will lead to rise in number of registered cannabis manufacturers, which explains that additional green light in research on cannabis, a strong move which increases the call for laboratory services. A superficial search of the medical literature shows that there are over 4,000 articles on cannabis on pain management. One of the biggest drivers is adult frivolous use, which is legal in some of the states in US. Meanwhile, in 2016, cannabis for medicinal purpose has received major support, claiming 89% of Americans allegedly support legalization versus 74% in 2011 and approximately 25 states have legalized medical cannabis, while several more are on track to do so boosting the cannabis testing market globally.

HPLC technology to gain the major market share in cannabis testing market in the U.S. and Asia

The global cannabis testing market is segmented on the basis of testing application, testing solutions and geography. On the basis of testing application, the market is divided into potency testing, terpene testing, residual solvent, pesticide screening and others. The others in market in testing application includes heavy metals and moisture content. On the basis of testing solutions, the market is divided into High Performance Liquid Chromatography, Gas Chromatography, Gas Chromatography Mass Spectrometry, inductively coupled plasma-mass spectrometric and others. The others in market includes Liquid Chromatography Mass Spectrometry, and Inductively Coupled Plasma in testing solutions.

Increasing research centers and testing laboratories in U.S. to boost the Cannabis Testing Market in North America

Regional segmentation in Cannabis Testing Market by Coherent Market Insights comprises of North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America accounts for the largest share in the market, mainly due to legalization of cannabis testing and use of them in medicinal purpose in many states of North America. According to GenTech Scientific, cannabis is also used in medical field and can treat various medical conditions such as cancer, eye disorder, convulsions, HIV/AIDS, and more. There are many research and lab testing facilities in US which are primarily focused on providing services to the cannabis industry, some of the research labs are Aegis Biotech, Agricor Laboratorie, Al-tar Services Inc, A2LA, Analytical 360, and Anresco Laboratorie etc

Request to view table of content @ https://www.coherentmarketinsights.com/ongoing-insight/toc/170

Companies are collaborating with national universities to develop the varied instruments in a short time

Key players operating the cannabis testing market include Cannabix Technologies., GenTech Scientific, and Shimadzu Scientific Instruments. The key players in the market are constantly working towards developing innovative instruments in order to provide accurate test results. Cannabix is presently focused on developing drug-testing devices which will detect Tetrahydrocannabinol by just the use of breath samples.

About Us:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity

Contact Us:

Mr.Shah

Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154

Tel: +1-206-701-6702

E-mail:sales@coherentmarketinsights.com

Website: https://www.coherentmarketinsights.com

Advertisements

Sterility Testing Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016-2024

Sterility Testing Market Overview:

Sterility testing in pharmaceutical manufacturing is a vital process during the sterilization and validation process along with release testing. It is an essential part of every sterilization validation process in several industries that makes it a vital procedure in manufacturing industry. It is an extremely difficult process that should be planned and executed with precision, which can be helpful in eliminating false positive results. Laboratory contamination or technician errors are the main causes of false positive results. Planned testing should be carried out in a clean room, where there is no or minimum chances of error are seen. This would also ensure compliance with U.S. Pharmacopeia (USP) requirements in terms of viable microbial air and surface counts. The unique requirements to employ sterility testing procedures as an official test and to determine the suitability are regulated under the good manufacturing practices guidelines.

An understanding of sterility testing benefits in validation process, designing is an important quality assurance issue is the need of providing an appropriate and authentic sterility test data. Furthermore, sterility testing is a tedious and artful process, which requires to be carried out by trained professionals. Also, investigation during the failure of sterility test, is a process that needs close look in environmental data along with other factors such as sample collection and sample procurement procedures. The rise in demand for sterilized products and their exclusivity in various industries is expected to fuel growth of the sterility testing market in the near future. The growth media utilized during the sterility testing must be properly prepared and tested to make the microbial growth adequately efficient. Increasing advancements in terms of sterility testing technologies is expected to support the sterility testing market growth over the forecast period (2016-2024). Various organizations are laying efforts in making the testing process more time efficient. For instance, Milliflex Rapid System, launched in 2010, for making the sterility testing procedure more time efficient without hindering the test result quality. The following decade is expected to provide major growth traction to players involved in the sterility testing market.

Fill the form for an exclusive sample of this report @ https://www.coherentmarketinsights.com/insight/request-sample/174

Sterility Testing Market Taxonomy:

By Product Type

Kits and Reagents

Instruments

Service

By Test Type

Membrane Filtration

Direct Inoculation

Container closure integrity testing

Antimicrobial effectiveness testing

Rapid micro test

ATP bioluminescence

Fluorescent labeling

Electrical resistance

By Application

Pharmaceutical and Biological Manufacturing

Medical Devices Manufacturing

Bioburden Test

Others Applications

Novel Technology in the pharmaceutical testing market is expected to favor the growth in sterility testing market:

Conventionally used microbiological testing methods for detection, enumeration, sterilization and identification tend to use culture methods majorly and were so often time consuming and labor-intensive. The drawback of such procedures in practical considerations often limits the extent to which microbiological tests applied regularly in both formulation development stage and for microbiological quality assurance. Furthermore, there are various well latest and upcoming methods such as MF sterility test apparatus from Merk Millipore, which is aseptically filter liquid samples for sterility testing apparatus used in sterility testing and may find wide application in the pharmaceutical sector. This is expected to be one of the important factors supporting growth of the sterility testing market. Rapid testing methods such as ATP bioluminescence, fluorescent labeling, nucleic acid probes and electrical resistance are commonly used in pharmaceutical testing. Obtaining perfect results by incorporating single method for all requirements is challenging, as products vary in their specifications, which is need to be adapted by the specific demands of the pharmaceutical and medical device situation. However, it is satisfactory to have the developments in ATP bioluminescence offering with increased sensitivity under adenylate kinase amplification potential specificity, phage lysis and internal calibration against the effects of excipients, laser scanning cytometry can be benefited through more specificity in proposed development using fluorescently labeled antibodies.

Major players in the sterility testing market are engaged in research and development process. For instance, bioMérieux SA – a biopharmaceutical company engaged in world class products for in-vitro testing – launched The BacT/ALERT 3D Dual-T apparatus for rapid and easy product control with non-destructive, dual-temperature microbial detection system.

Request to view table of content @ https://www.coherentmarketinsights.com/ongoing-insight/toc/174

Presence of major players in parenteral product manufacturing is projected to favor growth of the sterility testing market

The global sterility testing market is highly competitive and fragmented. Major players in the market are developing novel products through major spending on research and development to get a competitive edge over their counterparts. For instance, due to the strong product pipeline under market segment, Merck Millipore and bioMérieux are considered to be the toughest competitor in the market. Key players operating in the sterility testing market include Merck Millipore, Thermo Fisher Scientific, Inc., bioMérieux SA, SGS S.A., Sartorius AG, WuXi AppTec, and Charles River Laboratories International, Inc.

About Us:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity

Contact Us:

Mr.Shah

Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154

Tel: +1-206-701-6702

E-mail:sales@coherentmarketinsights.com

Website: https://www.coherentmarketinsights.com

Prefilled Syringes Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016-2024

Prefilled Syringes Market Overview:

Parenteral drugs are the second most preferred type of drugs after oral solid dosage forms and also holds second largest market share in terms of revenue in overall pharmaceutical market. Various benefits such as ease in administration, better patient compliance and 100% bioavailability are the few important factors that are expected to favor growth of the prefilled syringes market over the forecast period (2016–2024). Prefilled syringes segment is the one of the most important of the parenteral products market. However, volume sales in the market is rather low as it is a fairly novel product. The market is expected to gain traction over the forecast period, with increasing number of products and growing awareness among the populace about the benefits of the product. There are various factors such as ease in administration and minimum contact with the exposed environment that are expected to favor growth of the prefilled syringes market in the near future. Use of syringes with prefilled drugs would be especially useful in emergency situations. According to Drug Development & Delivery, around 3.5 billion of prefilled syringes are produced each year and the existing numbers are expected to grow by the rate of around 9.0 – 10% annually.

Fill the form for an exclusive sample of this report @ https://www.coherentmarketinsights.com/insight/request-sample/162

Prefilled Syringes market taxonomy:

By Application

Monoclonal Antibodies

Vaccines

Others

By Material Type

Polymer

PVC

Cyclo-olefin Polymer(COP)

Glass

By Design

Single Chambered

Dual Chambered

Multi-Chambered

Rising demand for biologics and self-injection products to augment market growth

A large number of newly approved biologics and drugs demand for PFS delivery devices for the subcutaneous (SC) self-injection of biopharmaceuticals. Also, the need for simpler self-injection procedures and improved patient compliance for auto injectors, large-volume patch injectors and pens is on the rise. This in turn is expected to favor growth of the prefilled syringes market over the forecast period (2016–2024). Patient exposure towards the routine injection can affect patient compliance, as it can cause significant discomfort to the user. Introduction of large volume biologics though, have helped rise in adoption rate of prefilled syringes. This in turn is expected to favor the market over the forecast period. Some factors such as growth in adoption of injectable drugs, success and growth of biologics, increased global vaccination, increased drug self-administration trend, technological advancements in the manufacture of PFS, and development of advanced PFS would further augment market growth.

Rise in number of applications is to favor the expansion of global prefilled syringes market:

Prefilled syringes market is expanding rapidly globally due to its various applications in overall healthcare sector. Nowadays, PFS manufacturing companies are focused on promoting use of the product in various application especially in homecare settings, which further is projected to favor increase in customer base in various regions. Furthermore, manufacturers are working towards developing PFS vaccines to help in indications such as various infectious disease and cancer. PFS are also being efficiently used in emergency medical services and in emergency section of hospitals. According to Frederick Furness Publishing Ltd, around 70% of atropine syringes prepared by the hospital staff are pre-filled and can be immediately used in emergency conditions.

Request to view table of content @ https://www.coherentmarketinsights.com/ongoing-insight/toc/162

Highly consolidated market is expected to favor the sales revenue of prefilled syringes market:

There are around 20 pharmaceutical companies that are involved in manufacturing and marketing of prefilled syringes as preferred delivery device of around 50 injectable drugs and vaccines, which contributes significantly to the sales revenue of these players. Furthermore, there are few recent acquisitions by the big brands in market of prefilled syringes such as in 2012, Becton Dickinson and Company acquired Safety Syringes, Inc., which is further expected to favor the company’s syringes manufacturing efficiency and increase its product portfolio. Key players operating in the prefilled syringes market include Becton Dickinson & Co., Gerresheimer, Medtronic, Baxter International, SCHOTT AG, West Pharmaceuticals, Vetter International, Unilife Corporation, Stevanato Group, and Terumo Corporation

About Us:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity

Contact Us:

Mr.Shah

Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154

Tel: +1-206-701-6702

E-mail:sales@coherentmarketinsights.com

Website: https://www.coherentmarketinsights.com

Cell Culture Market To Surpass US$ 22.5 Billion By 2024

The Global Cell Culture Market was valued at US$ 12,251.3 million in 2015 and is projected to expand at a CAGR of 7.1% during the forecast period (2016–2024),as highlighted in a new report published by Coherent Market Insights.The last century has witnessed a steep rise in number of deadly viruses that cause various diseases. Rise in number of virus infections is expected to propel the cell culture market in the near future. According to W.H.O, in 2015, prevalence of human immunodeficiency virus (HIV) infection in the U.S. is estimated to be 0.32%, which inadvertently fuels growth of the cell culture market.

To know the latest trends and insights prevalent in the Cell Culture market, click the link below:

https://www.coherentmarketinsights.com/market-insight/cell-culture-market-116

Cell culture is an important tool used in the field of molecular biology that offers excellent model systems for studying and analyzing normal physiology and biochemistry of cells. Furthermore, cell culture technique is used in drug screening and development and manufacturing of various biological compounds such as vaccines and therapeutic proteins. Rise in demand for animal and human vaccines is projected to support the cell culture market over the forecast period. High-income countries are characterized by high demand for vaccines in terms of value as compared to low-income countries, as the healthcare standards and awareness about the vaccinations is more in the former. According to WHO, in 2015, high-income countries contributed around 80% of global vaccine sales in terms of value, while accounting for under 20% sales volume. Conversely, around 20% of the global vaccines sales is from the low and middle-income countries contributing to the 80% of the volume of the total vaccines sold. Certain non-profit organizations such as UNICEF and PAHO have high power for low-income countries and middle-income countries. According to WHO, in 2011, the estimated purchase by such groups was around US$ 1.4 billion, which accounted for 7% of the total sales globally.

 

Fill the form for an exclusive sample of this report @ https://www.coherentmarketinsights.com/insight/request-sample/116

Product from cell culture are to be utilized as a biomarker for serious conditions such as cancer and also for clinical and diagnostic purpose in various other disease. Centrifugation technique is used for isolation of exosome, which is present in almost every fluid in humans. Companies are focusing on development of new methods for betterment of future healthcare. The implication of exosomes may be in various disorders such as cardiovascular disorder, Alzheimer’s, Parkinson’s and HIV. According to the latest updates in 2017 by International Labmate Limited, the Beckman Coulter’s life sciences division is involved in exosomes isolation process, which concluded that exosomes work under cell-to-cell communication process that is critical for homeostasis. They are further being studied and analyzed for their therapeutic efficiencies under nano delivery device to affected cells. Although the cell culture field consists of various products, their properties can be utilized to clinically treat and diagnose various abnormalities in humans and animals. Companies are inclined towards providing specific products to the customers. For instance, Becton Dickinson (BD) offers customized products and services for characterization of cells and defined environment for cell culture to the customers involved in drug discovery, and cell biology. BD’s custom products and services offers with dependable, reproducible tools. Such tools are able to reduce risks related to technology and finances, which in turn is expected to improve the research quality and operational benefits.

Key takeaways of the market:

  • The global cell culture market is expected to expand at a CAGR of 7.1% during the forecast period (2016–2024). The increase in number of cancer patients globally is expected to favor the market for cell culture in the near future. According to, Surveillance Research Program, in NCI’s Division of Cancer Control and Population Sciences, based on data available between 2009 and 2013, number of new cases of cancer of any site was 448.7 per 100,000 per year.
  • The instrument product type segment in the global cell culture market was estimated to be the largest in 2015 and is expected to dominate the market throughout the forecast period in terms of value. Rise in number adoption for vaccination worldwide in lower and middle-income countries in terms of volume. According to W.H.O, in 2016, around 19.4 million infants are still deprived of necessary vaccinations.
  • The cancer research application segment is expected to expand at a CAGR of 8.0% during the forecast period. This is expected to support the market on the backdrop of increase in global biopharmaceutical market due to the cost-effectiveness and high efficacy of the products.
  • The global cell culture market is characterized by rise in focus on biopharmaceutical and other biological products. For instance, according to McKinsey & Company, in 2015, biopharmaceuticals contributes to around 20%, which is around US$163 billion of the total pharma market. This is expected to increase and to support the cell culture market.

    Get Discount For First Time Buyers@ https://www.coherentmarketinsights.com/insight/request-discount/116

  • Some of the major players are Becton, Dickinson and Company, EMD Millipore, Sartorius AG, Merck KGAA, Biospherix, Sigma-Aldrich Corporation, Biovest International Inc. Cell Culture Company, LLC.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Raj Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com

Website:https://www.coherentmarketinsights.com

Oxygen Therapy Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016-2024

Oxygen Therapy Market Overview:

Oxygen therapy is the use of oxygen as medical intervention to maintain enough oxygen in conditions such as hypoxia, hypoxemia, and other related conditions. Oxygen may be administered through a nasal cannula, face mask, or through hyperbaric oxygen chamber. This therapy helps maintain oxygen level in the blood for treatment of acute and chronic diseases such as chronic obstructive diseases (COPD), pneumonia, and asthma. Long-term therapy with oxygen is often useful in people suffering from COPD. Certain other acute or chronic disease conditions where oxygen therapy is effective include cystic fibrosis, dysplasia, heart failure, sleep apnea, and lung disorders.

Fill the form for an exclusive sample of this report @ https://www.coherentmarketinsights.com/insight/request-sample/97

Oxygen therapy market taxonomy

The global oxygen therapy market is segmented on basis of source equipment, application, delivery device, and end use. By type of source equipment, the market in oxygen therapy is segmented into oxygen cylinders, liquid oxygen devices, and oxygen concentrators. On the basis of device type, the the oxygen therapy industry is segmented into nasal cannula, face mask, bag valve mask, venturi mask, oxygen mask, non-rebreather mask, and CPAP devices. On the basis of application, the global oxygen therapy market is as asthma, cystic fibrosis, COPD, pneumonia, respiratory distress syndrome, and cardiovascular diseases.

Oxygen therapy is used in hospitals to cure patients suffering from respiratory diseases such as COPD and pneumonia, and also cardiovascular diseases fueling growth of the oxygen therapy market. Oxygen therapy is also used in clinics, rehabilitations centers and home care settings .

Increasing incidence of COPD and lung disorders drive growth of the oxygen therapy market across the globe

Factors such as high prevalence of respiratory related diseases, growing aging population, and increasing vulnerability of the populace to respiratory conditions are fueling growth of the oxygen therapy market in North America. According to the Center for Diseases Control and Prevention (CDC), around 15.7 million people in the U.S. were diagnosed with COPD in 2013. Other factors driving demand for oxygen therapy include innovation in portable oxygen concentrators, rise in number of untreated sleep apnea cases, favorable reimbursement scenario, growing demand for oxygen filling devices, good medical facilities, and high investment in research and development activities. The European market in oxygen therapy is also gaining traction in recent times, mainly fueled by increasing number of patients suffering from respiratory diseases and favorable government initiatives to facilitate respiratory care.

According to the World Health Organization, over 90% of COPD deaths occur in low income and middle income countries. Therefore, the oxygen therapy market is expected to grow substantially in African, Asian, and Latin American countries due to high prevalence of COPD and deaths due to the disease. Furthermore, increasing awareness among medical facilities, increasing government investment in healthcare facilities, and availability of low cost treatment is projected to drive demand for oxygen therapy in emerging economies.

Alarming increase in number of lung damage cases increasing demand for oxygen therapy for effective treatment

According to World Health Organization (WHO) over 3 million people die each year due to COPD. Increasing use of oxygen therapy in treatment of diseases such as COPD, asthma, obstructive sleep apnea, and respiratory distress syndrome is a supportive prevalent trend in the market. Long-term oxygen therapy for patients suffering from chronic lung disease can help improve quality and length of life, in turn creating a favorable environment for the market. Increasing risk of lung damage due to tobacco consumption, occupational hazards, and pollution would further augment market growth over the following decade.

Request to view table of content @ https://www.coherentmarketinsights.com/ongoing-insight/toc/97

Global players engaged in the oxygen therapy market

There are several medical device companies, both local player and global ones, engaged in manufacture of oxygen therapy devices. Some of the prominent players are Respironics, Inc. (a Philips company), Fisher & Paykel Healthcare Limited, Teleflex Incorporated, Invacare Corporation, AirSep Corporation, CareFusion Corporation, DeVilbiss Healthcare, MAQUET Holding B.V. & Co. KG, and ResMed, Inc.

About Us:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity

Contact Us:

Mr.Shah

Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154

Tel: +1-206-701-6702

E-mail:sales@coherentmarketinsights.com

Website: https://www.coherentmarketinsights.com

Dental 3D Printing Devices Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016–2024

Dental 3D Printing Devices Market Overview:

Dental 3D printing is additive manufacturing used to create 3-dimentional image for incorporating several layer of image for building material. These objects are produced from a digital 3D blueprint like a computer-aided design or MRI scan. These devices allow the designers to make changes in the design without any additional tool or equipment. Dental 3D printing combines high quality 3D printing technology with a wide variety of dental materials. This technology is adopted by dentists, orthodontists, and dental labs. It is cost effective and allows for extensive customizations that allow for better designing. This allows dental practitioners to design the product based on the various factors of patient like age, height, weight, and medical history. These methods can be used by dental practitioners to replace teeth, veneers, crowns, and inlays in a single sitting.

Fill the form for an exclusive sample of this report @ https://www.coherentmarketinsights.com/insight/request-sample/105

Global Dental 3D Printing Devices Market Taxonomy

The global dental 3D printing devices market is classified on the basis of the following segments product type, technique, application, and end user of the dental 3D printing device:

  • Product Type:

    • Printers

    • Software

    • Components

  • Technique:

    • Digital Light Projection

    • 3D Jet Printing

    • Stereo Lithography Apparatus (SLA) 3D Printing

    • Selective Laser Sintering (SLS)

    • Direct Laser Metal Sintering (DLMS)

  • Application Type:

    • Orthopedic Implants

    • Dental Restoratives

      • Crowns

      • Surgical instruments

      • Others

Dental 3D printing allows designing of dental crowns, prosthetics, implants, bone replacement, and customized devices based on requirement.

  • End Users of dental 3D printing devices:

    • Hospitals

    • Dental Clinics

    • Ambulatory Surgical Centers

    • Others

According to the World Health Organization (WHO) in 2012, prevalence of cavities was 60–90% in children up to the age of 15 years and 100% in adults. Furthermore around 15–20% of people aged from 35–44 years were suffering from severe periodontal disease that could lead to loss of the affected tooth. This rise in prevalence of dental disorders globally is expected to favor rise in uptake of cosmetic and maxillofacial surgeries associated with mouth disorder, which in turn is increasing demand for dental 3D printing devices.

Major dental 3D printing devices:Planmeca Creo (Planmeca), Form 2 (Formlabs), Mysint 100 (Sisma 3D), Moonray (SpintRay), Projet MJP 3600 (3D Systems), Project 6000(3D Systems), Roboze one (Roboze S.r.l.) etc.

Request to view table of content @ https://www.coherentmarketinsights.com/ongoing-insight/toc/105

Increasing influx of dental tourists and cost-effectiveness of 3D printed devices to fuel market growth

Developed economies such as the U.S., U.K., Germany, and France experience high rate of adoption due to better healthcare facilities and easy availability in these countries. As per the report of the American Academy of Periodontology, in 2012, around half of the adult population in the U.S. suffered from gum disease, of which 47.2% were reported to be suffering from periodontitis. This number is expected to increase significantly over the forecast period, owing to increasing changes in lifestyle and growing geriatric population Increasing number of dental clinics and hospitals and growing number of experienced dental practitioners in Asia Pacific region, supplemented by rising influx of dental tourists is expected to significantly boost growth of the dental 3D printing devices market in these regions.

Devices with comprehensive range of features

Companies are focusing on launching new devices to the market with advanced features and technology to provide better imaging facilities to the practitioners for service, for instance, GE Healthcare are prepared to utilize 3-D printing technology in ultrasound probes previously used in medical services for diagnosing the health of a fetus, although now the technique is useful where any type of noninvasive inspections are being carried out. Furthermore, in March 2015, Germany-based Bego launched a new system with a unique cartilage system that allow multiple materials to be used at the International Dental Show. In May 2016, Planmeca launched a new 3D printer with powerful 3D features that fulfills demands of cheap and high quality image of additive manufacturing in healthcare.

Fragmented Market

The global dental 3D printing devices market is highly fragmented, owing to the participation of many established and emerging players in the dental imaging market. Various players in the dental 3D printing devices market are integrating proprietary technologies of 3D printing to develop with novel products and product advancements in order to differentiate their offerings. For example, 3D System Corporation projet 3510 MP would use 3Shape Implant Studio, which includes implant planning and surgical guides for the patient that benefits the patients by reducing chair time and provides digital accuracy by reducing manual errors. The combination is expected to manufacture fully functional dental implants. Some of the major players involved in the dental 3D printing devices market are EnvisionTEC, Javelin Technologies, Formlabs Inc., 3D Systems GMBH, Stratasys, Prodways, Roboze, and ASIGA.

About Us:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity

Contact Us:

Mr.Shah

Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154

Tel: +1-206-701-6702

E-mail:sales@coherentmarketinsights.com

Website: https://www.coherentmarketinsights.com